Filters
Tests names and labs | Conditions | Genes, analytes, and microbes | Methods |
---|---|---|---|
LGI1 - NGS including CNV analysis Centogene AG - the Rare Disease Company Germany | 1 | 1 |
|
Centogene AG - the Rare Disease Company Germany | 1886 | 1858 |
|
Centogene AG - the Rare Disease Company Germany | 734 | 744 |
|
Invitae Hypogonadotropic Hypogonadism Panel Invitae United States | 67 | 46 |
|
Invitae Brain Malformations Panel Invitae United States | 247 | 161 |
|
Intergen Intergen Genetics and Rare Diseases Diagnosis Center Turkey | 1 | 1 |
|
Intergen Intergen Genetics and Rare Diseases Diagnosis Center Turkey | 1 | 1 |
|
Invitae United States | 466 | 297 |
|
Epilespy, Autosomal Dominant Lateral Temporal, via the LGI1 Gene PreventionGenetics, part of Exact Sciences United States | 1 | 1 |
|
Institute for Human Genetics University Medical Center Freiburg Germany | 1 | 1 |
|
Comprehensive Epilepsy Panel, Sequencing and Deletion/Duplication ARUP Laboratories, Molecular Genetics and Genomics ARUP Laboratories United States | 234 | 240 |
|
Epilepsy familial temporal lobe 1 (sequence analysis of LGI1 gene) CGC Genetics Unilabs Portugal | 1 | 1 |
|
Generalized idiopathic and focal epilepsy panel. 34-gene NGS panel. Genologica Medica Spain | 74 | 34 |
|
Complete epilepsy panel. NGS panel of 283 genes. Genologica Medica Spain | 409 | 283 |
|
CNH Molecular Diagnostics Laboratory Childrens National Hospital United States | 132 | 83 |
|
Epilepsy, familial temporal lobe: Full gene sequencing panel CEN4GEN Institute for Genomics and Molecular Diagnostics Canada | 4 | 4 |
|
Fulgent Genetics United States | 354 | 209 |
|
Adolescent/Adult Epilepsy NGS Panel Fulgent Genetics United States | 182 | 82 |
|
EPILEPSY,LATERAL TEMPORAL LOBE (AUTOSOMAL DOMINANT) Laboratorio de Genetica Clinica SL Spain | 1 | 1 |
|
Epilepsy Advanced Sequencing and CNV Evaluation - Syndromic Disorders Athena Diagnostics United States | 30 | 31 |
|
IMPORTANT NOTE: NIH does not independently verify information submitted to the GTR; it relies on submitters to provide information that is accurate and not misleading. NIH makes no endorsements of tests or laboratories listed in the GTR. GTR is not a substitute for medical advice. Patients and consumers with specific questions about a genetic test should contact a health care provider or a genetics professional.